NAME
CAS#
THERAPEUTIC INDICATION
DMF
2-Aminoheptane Sulfate
6411-75-2
Decongestant
EU
Alverine Citrate
5560-59-8
Antispasmodic
EU - KR
Amifampridine Phosphate
446254-47-3
Lambert-Eaton Myasthenic Syndrome
EU
Carglumic Acid
1188-38-1
Hyperammonaemia
EU - US
Carprofen [VET]
53716-49-7
Anti-Inflammatory
EU - US
Chlophedianol Hydrochloride
511-13-7
Antitussive
JP - EU - US
Chloropyramine Hydrochloride
6170-42-9
Antihistaminic
EU
Dalfampridine
504-24-5
Multiple sclerosis
EU - US
Efinaconazole
164650-44-6
Antifungal
EU - US - KR - JP - CA - BR
Felbamate
25451-15-4
Anti-Epilectic
EU - US
Guanfacine Hydrochloride
29110-48-3
Antihypertensive ADHD treatment
EU - US - CA
Iloperidone
133454-47-4
Antipsychotic Schizophrenia
EU - US
Isopropamide Iodide
71-81-8
Antispasmodic
EU
Istradefylline
15520-99-8
Anti-Parkinson
EU - US
Labetalol Hydrochloride
32780-64-6
Antihypertensive
EU - US - JP - CA - BR
Landiolol Hydrochloride
144481-98-1
Antiarrythmic
JP - EU
Levosulpiride
23672-07-3
Antipsychotic Gastroprokinetic
EU
Lofexidine Hydrochloride
31036-80-3
Opioid use disorder
EU - US
Lurasidone Hydrochloride
367514-88-3
Antipsychotic schizophrenia and bipolar disorder
EU - US - BR
Maropitant [VET]
147116-67-4
Antiemetic
EU - US
Maropitant Citrate Monohydrate [VET]
359875-09-5
Antiemetic
EU - US - CA
Memantine Hydrochloride
41100-52-1
Alzheimer disease
JP - EU - US - KR - BR
Methoxyphenamine Hydrochloride
5588-10-3
Bronchodilator
JP - EU
Midostaurin
120685-11-2
Acute myeloid leukemia Myelodysplastic syndrome
EU - US
Minodronic Acid Hydrate
155648-60-5
Osteoporosis
JP - EU
Naftidrofuryl Oxalate
3200-06-4
Vasodilator
EU - KR
Naftopidil
57149-07-2
Benign prostatic hypertrophy
JP - EU
Nalfurafine Hydrochloride
152658-17-8
Antipruritic
JP - EU
Orphenadrine Citrate
4682-36-4
Antihistaminic
EU - US - BR
Orphenadrine Hydrochloride
341-69-5
Anti-Parkinson
EU
Phenelzine Sulfate
156-51-4
Antidepressant
EU - US
Pirfenidone
59179-13-8
Idiopathic Pulmonary Fibrosis
EU - US - CEP - BR
Propafenone Hydrochloride
34183-22-7
Antiarrhythmic
EU - US - JP - CA - BR
Pyridostigmine Bromide
101-26-8
Antimyasthenics
CEP - EU - US - KR - CA - BR
Tapinarof
79388-84-4
Plaque Psoriasis
EU
Tipiracil HCl / Trifluridine
183204-72-0
Colonrectal and Gastric cancer
EU
Trifluridine
70-00-8
Antiviral Ophthalmic
EU
Trospium Chloride
10405-02-4
Overactive Bladder
EU - US - CA
Products are offered for sales only in countries where related patents have already expired. Products still covered by patents are available exclusively for experimental purpose pursuant to national applicable law. Any use and/or commercialization in breach of the above will be made under your sole responsibility.